Logotipo del repositorio

Análisis de características clínicas y etiológicas de pacientes con miocarditis aguda en un hospital de alta complejidad de atención en salud

Vista sencilla de ítem
dc.contributor.advisorManuel , Alvarez Gaviria
dc.contributor.authorReyes Toledo , Raul Eduardo
dc.contributor.authorRoa Culma, Laura Alejandra
dc.contributor.orcidReyes Toledo, Raul Eduardo [0000-0001-5427-7679]
dc.contributor.orcidRoa Culma, Laura Alejandra [0000-0001-5084-2263]
dc.date.accessioned2025-02-13T21:01:36Z
dc.date.available2025-02-13T21:01:36Z
dc.date.issued2024-11
dc.description.abstractIntroducción La miocarditis aguda (MA) se define como una enfermedad inflamatoria del miocardio con etiología diversa que tiene un comportamiento clínico y pronostico variable. Este estudio busca identificar cual es la naturaleza del comportamiento de esta enfermedad en nuestro medio. Objetivos Describir el comportamiento clínico y etiológico de la miocarditis aguda durante un periodo de evaluación de 9 años en un centro de referencia en salud en Bogotá, Colombia. Material y métodos Estudio descriptivo de corte transversal. Se seleccionaron mediante muestreo por conveniencia todos los casos de MA identificados por código CIE-10 que cumplieran criterios diagnósticos de miocarditis clínicamente sospechada o tuvieran hallazgos de resonancia magnética cardiaca confirmatorias. Resultados Se identificaron 97 pacientes con diagnóstico de miocarditis aguda. 63,9% de los casos fueron hombres con una edad promedio de 39 años. La tasa de comorbilidades fue baja, siendo la hipertensión arterial crónica (15.5%), obesidad (12.4%) y diabetes mellitus (9,3%) las comorbilidades más prevalentes. El dolor torácico fue el síntoma cardinal y aproximadamente 1 de cada 3 pacientes tuvieron el pródromo de una infección respiratoria o digestiva. El diagnóstico etiológico especifico es infrecuente. La pericarditis aguda (19.6%) y falla cardiaca aguda (17.4%) fueron las complicaciones más frecuentes. La tasa de mortalidad global fue de 5.2%. Conclusiones El comportamiento clínico y sociodemográfico de nuestra cohorte es muy similar a lo descrito en registros internacionales. La caracterización etiológica es escasa, destacando un aumento de casos durante la pandemia de COVID 19 y la presencia de infecciones. A pesar de avances en el diagnóstico oportuno y tratamiento de la MA, no hay modificación en la tasa de mortalidad intrahospitalaria y complicaciones asociadas. Esperamos que esta investigación motive el desarrollo de nuevas investigaciones en nuestro medio en el campo de la MA que permita fortalecer las estrategias de salud pública con el objetivo de mitigar el impacto de la morbilidad y mortalidad de esta condición.
dc.description.abstractenglishIntroduction Acute myocarditis (AM) is defined as an inflammatory disease of the myocardium with diverse etiology, exhibiting variable clinical and prognostic behavior. This study aims to identify the nature of the disease's progression in our setting. Objectives To describe the clinical and etiological behavior of acute myocarditis over a 9-year evaluation period at a reference healthcare center in Bogotá, Colombia. Material and Methods A descriptive, cross-sectional study was conducted. All cases of AM identified by the ICD-10 code that met diagnostic criteria for clinically suspected myocarditis or had confirmatory findings on cardiac magnetic resonance imaging were selected through convenience sampling. Results A total of 97 patients diagnosed with acute myocarditis were identified. 63.9% of the cases were male, with a mean age of 39 years. The comorbidity rate was low, with chronic hypertension (15.5%), obesity (12.4%), and diabetes mellitus (9.3%) being the most prevalent comorbidities. Chest pain was the cardinal symptom, and approximately 1 in 3 patients had a prodrome of a respiratory or digestive infection. Specific etiological diagnosis was uncommon. Acute pericarditis (19.6%) and acute heart failure (17.4%) were the most frequent complications. The overall mortality rate was 5.2%. Conclusions The clinical and sociodemographic characteristics of our cohort closely resemble those described in international registries. The etiological characterization is scarce, with an increase in cases during the COVID-19 pandemic and the presence of infections. Despite advances in the timely diagnosis and treatment of AM, there has been no modification in the in-hospital mortality rate or associated complications. We hope this research will encourage the development of further studies in our region on AM, which will strengthen public health strategies aimed at mitigating the morbidity and mortality impact of this condition.
dc.description.degreelevelEspecializaciónspa
dc.description.degreenameEspecialista en Cardiología de Adultosspa
dc.description.sponsorshipFundación Santa Fe de Bogotá
dc.format.mimetypeapplication/pdf
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/13951
dc.language.isoes
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.grantorUniversidad El Bosquespa
dc.publisher.programEspecialización en Cardiología Adultosspa
dc.relation.references1. Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, Pedrotti P, Rimoldi OE, Schultheiss HP, Tschöpe C, Cooper LT Jr, Camici PG. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12. PMID: 33176455; PMCID: PMC7673642.
dc.relation.references2 Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996 Mar 1;93(5):841-2. doi: 10.1161/01.cir.93.5.841. PMID: 8598070.
dc.relation.references3 Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol [Internet]. 2020 Dec 12 [cited 2022 Nov 14];76(25):2982. Available from: /pmc/articles/PMC7755038/}
dc.relation.references4 Ammirati E, Moslehi JJ. Diagnosis and Treatment of Acute Myocarditis: A Review. JAMA. 2023 Apr 4;329(13):1098-1113. doi: 10.1001/jama.2023.3371. PMID: 37014337.
dc.relation.references5 Lota AS, Hazebroek MR, Theotokis P, Wassall R, Salmi S, Halliday BP, Tayal U, Verdonschot J, Meena D, Owen R, de Marvao A, Iacob A, Yazdani M, Hammersley DJ, Jones RE, Wage R, Buchan R, Vivian F, Hafouda Y, Noseda M, Gregson J, Mittal T, Wong J, Robertus JL, Baksi AJ, Vassiliou V, Tzoulaki I, Pantazis A, Cleland JGF, Barton PJR, Cook SA, Pennell DJ, Garcia-Pavia P, Cooper LT Jr, Heymans S, Ware JS, Prasad SK. Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy. Circulation. 2022 Oct 11;146(15):1123-1134. doi: 10.1161/CIRCULATIONAHA.121.058457
dc.relation.references6 Kontorovich AR, Patel N, Moscati A, Richter F, Peter I, Purevjav E, Selejan SR, Kindermann I, Towbin JA, Bohm M, Klingel K, Gelb BD. Myopathic Cardiac Genotypes Increase Risk for Myocarditis. JACC Basic Transl Sci. 2021 Jul 26;6(7):584-592. doi: 10.1016/j.jacbts.2021.06.001.
dc.relation.references7 Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hübner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021 Mar;18(3):169-193. doi: 10.1038/s41569-020-00435-x
dc.relation.references8 Ammirati E, Lupi L, Palazzini M, et al. Prevalence, characteristics, and outcomes of COVID-19-associated acutemyocarditis. Circulation. 2022;145(15):1123-1139. doi:10.1161/ CIRCULATIONAHA.121.056817
dc.relation.references9 Wang X, Bu X, Wei L, Liu J, Yang D, Mann DL, Ma A, Hayashi T. Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017. Front Cardiovasc Med. 2021 Jul 2;8:692990. doi: 10.3389/fcvm.2021.692990. PMID: 34277742; PMCID: PMC8284556
dc.relation.references10 Liu ZY, Su ZH, Li WC, Zhang FW, Ouyang WB, Wang SZ, Xia RB, Li YK, Pan XB. Global, regional, and national time trends in myocarditis-related mortality, 1990-2019: An age-period-cohort analysis. Eur Rev Med Pharmacol Sci. 2023 Oct;27(19):9183-9191. doi: 10.26355/eurrev_202310_33946. PMID: 37843332.
dc.relation.references11 Rincon-Acevedo CY, Parada-Garcia AS, OliveraMJ, et al. Clinical and epidemiological characterization of acute Chagas disease in Casanare, Eastern Colombia, 2012-2020. Front Med (Lausanne). 2021;8:681635. doi:10.3389/fmed.2021.681635
dc.relation.references12 Rivillas Julian, Gonzalez -Jaramillo Nathalia, Roncancio-Villamil Gustavo, et al. Manifestaciones cardiovasculares en pacientes con dengue durante dos brotes epidémicos en Colombia. Medicina & Laboratorio. 2017; Vol. 23, Nº. 11-12, págs. 565-572.
dc.relation.references13 Martens P, Cooper LT, Tang WHW. Diagnostic Approach for Suspected Acute Myocarditis: Considerations for Standardization and Broadening Clinical Spectrum. J Am Heart Assoc. 2023 Sep 5;12(17):e031454. doi: 10.1161/JAHA.123.031454
dc.relation.references14 Seferovic PM, Tsutsui H, McNamara DM, Ristic AD, Basso C, Bozkurt B, Cooper LT Jr, Filippatos G, Ide T, Inomata T, et al. Heart failure association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society position statement on endomyocardial biopsy. Eur J Heart Fail. 2021;23:854– 871. doi:10.1002/ejhf.2190
dc.relation.references15 Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation. 2005 Feb 22;111(7):887-93. doi: 10.1161/01.CIR.0000155616.07901.35
dc.relation.references16 Ryan M, Montgomery J, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mrna covid-19 vaccines in members of the us military. JAMA Cardiol. 2021 Oct 1;6(10):1202–6.
dc.relation.references17 Vergara HD, Gómez CH, Faccini-Martínez ÁA, Herrera AC, López MJ, Camacho C, Muñoz L, Cruz-Saavedra L, Hernández C, Ramírez JD. Acute Chagas Disease Outbreak among Military Personnel, Colombia, 2021. Emerg Infect Dis. 2023 Sep;29(9):1882-1885. doi: 10.3201/eid2909.230886
dc.relation.references18 Olivera MJ, Fory JA, Porras JF, Buitrago G. Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis. PLoS One. 2019;14(1):e0210156.
dc.relation.references19 Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation [Internet]. 1999 Mar 2 [cited 2022 Nov 13];99(8):1091–100. Available from: https://pubmed.ncbi.nlm.nih.gov/10051305/
dc.relation.references20 Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, Mantovani R, Varrenti M, Pedrotti P, Conca C, et al; Registro Lombardo delle Miocarditi. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter lombardy registry. Circulation. 2018;138:1088–1099. doi: 10.1161/CIRCULATIONAHA.118.035319
dc.relation.references21 Younis A, Matetzky S, Mulla W, Masalha E, Afel Y, Chernomordik F, Fardman A, Goitein O, Ben-Zekry S, Peled Y, et al. Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis. Am J Med. 2020;133:492–499. doi: 10.1016/j.amjmed.2019.10.015
dc.relation.references22 Peretto G, Sala S, Basso C, Rizzo S, Radinovic A, Frontera A, Limite LR, Paglino G, Bisceglia C, De LG, et al. Inflammation as a predictor of recurrent ventricular tachycardia after ablation in patients with myocarditis. J Am Coll Cardiol. 2020;76:1644– 1656. doi: 10.1016/j.jacc.2020.08.012
dc.relation.references23 Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, Mantovani R, Varrenti M, Pedrotti P, Conca C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry. Circulation. 2018;138:1088– 1099. doi: 10.1161/CIRCULATIONAHA.118.035319
dc.relation.references24 Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636-48.
dc.relation.references25 Olsen EG. Histopathologic aspects of viral myocarditis and its diagnostic criteria. Heart Vessels Suppl. 1985;1:130-2. doi: 10.1007/BF02072379
dc.relation.references26 De Gaspari M, Larsen BT, d’Amati G, et al. Diagnosing myocarditis in endomyocardial biopsies:survey of current practice. Cardiovasc Pathol. 2022; 107494. doi:10.1016/j.carpath.2022.107494
dc.relation.references27 Ammirati E, Buono A, Moroni F, et al. State-of-the-art of endomyocardial biopsy on acute myocarditis and chronic inflammatory cardiomyopathy. Curr Cardiol Rep. 2022;24(5):597- 609. doi:10.1007/s11886-022-01680-x
dc.relation.references28 Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, et al. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2019;74:299–311. doi: 10.1016/j.jacc.2019.04.063
dc.relation.references29 Løgstrup BB, Nielsen JM, Kim WY, Poulsen SH. Myocardial oedema in acute myocarditis detected by echocardiographic 2D myocardial deformation analysis. Eur Heart J Cardiovasc Imaging. 2016 Sep;17(9):1018-26. doi: 10.1093/ehjci/jev302
dc.relation.references30 Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009 Apr;53(17):1475–87.
dc.relation.references31 Group JCSJW. Guidelines for Diagnosis and Treatment of Myocarditis (JCS 2009). Circ J. 2011;advpub:1102021098.
dc.relation.references32 Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018 Dec;72(24):3158–76.
dc.relation.references33 Fairweather, D., Cooper, L. T., & Blauwet, L. A. (2013). Sex and gender differences in myocarditis and dilated cardiomyopathy. Current Problems in Cardiology, 38(1), 7-46.
dc.relation.references34 Imazio M, Cooper LT. Management of myopericarditis. Am J Cardiol. 2013;111(3):321-327. doi:10.1016/j.amjcard.2012.09.027.
dc.relation.references35 Frustaci, A., Chimenti, C., & Ricci, R. (2007). Myocarditis: The state of the art. Current Opinion in Cardiology, 22(3), 270-277. doi:10.1097/HCO.0b013e3280ba6a56
dc.relation.references36 Kindermann, I., Barth, C., Mahfoud, F., et al. (2012). Update on myocarditis. Journal of the American College of Cardiology, 59(9), 783-790. doi:.org/10.1016/j.jacc.2011.11.072
dc.relation.references37 Lopérgolo F, et al. Role of Echocardiography in Acute Myocarditis Diagnosis and Prognosis. J Cardiovasc Imaging. 2021;29(1):15-23. doi:10.1016/j.jcvi.2020.10.002.
dc.relation.references38 Friedrich, M. G., et al. (2018). Cardiovascular Magnetic Resonance in Myocarditis: Techniques and Applications. Circulation: Cardiovascular Imaging. 11(2): e007155. DOI: 10.1161/CIRCIMAGING.117.007155.
dc.relation.references39 Mavrogeni, S., et al. (2017). Cardiac Magnetic Resonance in Myocarditis: Current Applications. Current Cardiology Reports. 19(10): 74. DOI: 10.1007/s11886-017-0895-0.
dc.relation.references40 Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52(4):274-288. doi:10.1016/j.pcad.2009.12.008.
dc.rightsAttribution-NoDerivatives 4.0 Internationalen
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.localAcceso abiertospa
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/
dc.subjectMiocarditis
dc.subjectEtiología
dc.subjectPronóstico
dc.subjectCardiomiopatía inflamatoria
dc.subjectResonancia magnética cardiaca
dc.subjectResultados de tratamiento
dc.subject.keywordsMyocarditis
dc.subject.keywordsEtiology
dc.subject.keywordsPrognosis
dc.subject.keywordsInflammatory cardiomyopathy
dc.subject.keywordsCardiac magnetic resonance imaging
dc.subject.keywordsTreatment outcomes
dc.subject.nlmWG 100
dc.titleAnálisis de características clínicas y etiológicas de pacientes con miocarditis aguda en un hospital de alta complejidad de atención en salud
dc.title.translatedAnalysis of clinical and etiological characteristics of patients with acute myocarditis in a high-complexity healthcare hospital
dc.type.coarhttps://purl.org/coar/resource_type/c_7a1f
dc.type.coarversionhttps://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.driverinfo:eu-repo/semantics/bachelorThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesis/Trabajo de grado - Monografía - Especializaciónspa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
Trabajo de grado.pdf
Tamaño:
481.99 KB
Formato:
Adobe Portable Document Format
Descargar

Bloque de licencias

Mostrando 1 - 3 de 3
Miniatura
Nombre:
license.txt
Tamaño:
1.95 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Miniatura
Nombre:
Carta de autorizacion.pdf
Tamaño:
317.31 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Miniatura
Nombre:
Anexo 1 Acta de aprobacion.pdf
Tamaño:
231.84 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar

Colecciones

Especialización en Cardiología Adultos

Software DSpace copyright © 2002-2025 LYRASIS